1.LI YT，CERCUEIL JP，YUAN J，et al.Liver intravoxel incoherent motion（IVIM）magnetic resonance imaging：a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation.Quant Imaging Med Surg.2017，7：59-78.

2.TAOULI B，KOH DM.Diffusion-weighted MR imaging of the liver.Radiology.2010，254：47-66.

3.CHEVALLIER O，ZHOU N，HE J，et al.Removal of evidential motion-contaminated and poorly fitted image data improves IVIM diffusion MRI parameter scan-rescan reproducibility.Acta Radiol.2018，59：1157-1167.

4.WÁNG YX，LI YT，CHEVALLIER O，et al.Dependence of intravoxel incoherent motion diffusion MR threshold b-value selection for separating perfusion and diffusion compartments and liver fibrosis diagnostic performance.Acta Radiol.2019，60：3-12.

5.TER VOERT EE，DELSO G，PORTO M，et al.Intravoxel Incoherent Motion Protocol Evaluation and Data Quality in Normal and Malignant Liver Tissue and Comparison to the Literature.Invest Radiol.2016，51：90-99.

6.WÁNG YX，DENG M，LI YT，et al.A Combined Use of Intravoxel Incoherent Motion MRI Parameters Can Differentiate Early-Stage Hepatitis-b Fibrotic Livers from Healthy Livers.SLAS Technol.2018，23：259-268.

7.HUANG H，CHE-NORDIN N，et al.High performance of intravoxel incoherent motion diffusion MRI in detecting viral hepatitis-b induced liver fibrosis.Ann Transl Med.2019，7：39.

8.WANG YX.Living tissue intravoxel incoherent motion（IVIM）diffusion MR analysis without b=0image：an example for liver fibrosis evaluation.Quant Imaging Med Surg 2019.doi：10.21037/qims.2019.01.07.

9.CERCUEIL JP，PETIT JM，NOUGARET S，et al.Intravoxel incoherent motion diffusion-weighted imaging in the liver：comparison of mono-，bi-and tri-exponential modelling at 3.0-T.Eur Radiol.2015，25：1541-50.

10.THOMSEN C，BECKER U，WINKLER K，et al.Quantification of liver fat using magnetic resonance spectroscopy.MagnReson Imaging.1994，12：487-495.

11.ST PIERRE TG，CLARK PR，CHUA-ANUSORN W，et al.Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.Blood.2005，105：855-861.

12.KANDA T，ISHII K，KAWAGUCHI H，et al.High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images：relationship with increasing cumulative dose of a gadolinium-based contrast material.Radiology.2014，270：834-841.

13.KANDA T，OSAWA M，OBA H，et al.High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images：Association with Linear versus Macrocyclic Gadolinium Chelate Administration.Radiology.2015，275：803.

14.DONATO H，FRANÇA M，CANDELÁRIA I，et al.Liver MRI：From basic protocol to advanced techniques.Eur J Radiol.2017，93：30-39.

15.NERI E，BALI MA，BA-SSALAMAH A，et al.ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.Eur Radiol.2016，26：921-931.

16.JHAVERI K，CLEARY S，AUDET P，et al.Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent（gadoxetic acid）.AJR Am J Roentgenol.2015，204：498-509.

17.MAUREA S，MAINENTI PP，TAMBASCO A，et al.Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions：comparison between gadolinium and superparamagnetic iron oxide contrast media.Quant Imaging Med Surg.2014，4：181-189.

18.DE HAEN C，CABRINI M，AKHNANA L，et al.Gadobenate dimeglumine 0.5 M solution for injection （Multi-Hance）pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium.J Comput Assist Tomogr.1999，23（Suppl 1）：S161-168.

19.BOKACHEVA L，RUSINEK H，CHEN Q，et al.Quantitative determination of Gd-DTPA concentration in T1-weighted MR renography studies.Magn Reson Med.2007，57（6）：1012-1018.

20.PETITCLERC L，SEBASTIANI G，GILBERT G，et al.Liver fibrosis：Review of current imaging and MRI quantification techniques.J Magn Reson Imaging.2017，45：1276-1295.

21.HUH J，KIM SY，YEH BM，LEE SS，et al.Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver.Korean J Radiol.2015，16：1207-1215.